Wealth Awesome
TSX open
Loading markets…
PARTNER SPOTLIGHT
CIBC Investor's Edge

Buy the stocks you believe in, for less

For a limited time, trade fractional shares commission-free.¹

  • ✓Own a piece of your favourite companies without buying an entire share
  • ✓Stocks and ETFs, from as little as $1
  • ✓In any account: TFSA, FHSA, RRSP and more

¹Online fractional trades in North American equities under one share, Sep 15, 2026 to Oct 31, 2027. One qualifying order per security, per side, per day. Conditions apply.

Insider · SEDI

Derek Elan Stern

Derek Elan Stern has reported about $43.5M in shares of Cannara Biotech Inc on SEDI, Canada's insider filing system. That is #206 among the insiders we track.

Holdings as of November 17, 2026 · Director

Disclosed holdings

$43.5M

Companies

1

Buys / sells (12 months)

0 / 0

Net bought (12 months)

—

How to read insider buying

An insider buy is someone putting their own money where their mouth is, and insiders have the closest view of the business. Founders and CEOs buying their own company is common. The more telling pattern is an experienced investor holding stakes across several companies and adding over time: big buyers rarely stop at one purchase, so the first filings can put you early.

The Saturday TSX Wrap · free, every saturday morning. The week on the TSX, in five minutes.

Holdings by company

Latest balance reported on SEDI for each company (direct and through holding companies), valued at the latest close.

CompanyRoleSharesValueLast filing
Cannara Biotech IncLOVE.V · all insidersDirectorincl. indirect23,793,560$43.5M2025-12-08

Track record after buying

Every open-market buy since 2016, and what the stock did 3, 6 and 12 months later (adjusted closes; same-day buys of one stock count once; each return capped at +300%). Ranked #126 on the insider track record.

Buys

33

Avg after 3 months

−7.2%

Avg after 6 months

−3.8%

Avg after 12 months

+31.9%

Up after 1 year

45% of 33

DateCompanyBought3 mo6 mo12 mo
2024-08-21Cannara Biotech IncLOVE.V$92K−13.0%+55.8%+142.9%
2024-08-15Cannara Biotech IncLOVE.V$44K−14.3%+80.0%+172.9%
2024-07-26Cannara Biotech IncLOVE.V$30K+4.7%+32.8%+179.7%
2024-05-21Cannara Biotech IncLOVE.V$5K−18.5%−27.2%+56.8%
2024-05-17Cannara Biotech IncLOVE.V$8K−16.0%−24.7%+63.0%
2024-05-16Cannara Biotech IncLOVE.V$8K−12.5%−25.0%+63.8%
2024-05-15Cannara Biotech IncLOVE.V$5K−18.2%−18.2%+66.2%
2024-05-14Cannara Biotech IncLOVE.V$5K−22.1%−22.1%+64.9%
2024-05-13Cannara Biotech IncLOVE.V$5K−19.8%−23.5%+65.4%
2024-05-10Cannara Biotech IncLOVE.V$16K−11.5%−15.4%+70.5%
2024-05-09Cannara Biotech IncLOVE.V$4K−11.5%−12.8%+69.2%
2024-05-08Cannara Biotech IncLOVE.V$4K−16.2%−12.2%+81.1%
2024-05-07Cannara Biotech IncLOVE.V$5K−18.4%−1.3%+71.1%
2024-02-29Cannara Biotech IncLOVE.V$50K−24.5%−26.5%+40.8%
2024-02-27Cannara Biotech IncLOVE.V$48K−27.0%−36.0%+29.0%
2023-05-31Cannara Biotech IncLOVE.V$134K+0.0%−12.6%−22.1%
2023-05-30Cannara Biotech IncLOVE.V$78K+0.0%−7.4%−22.1%
2023-05-29Cannara Biotech IncLOVE.V$11K+0.0%−7.4%−23.2%
2023-05-26Cannara Biotech IncLOVE.V$425+0.0%−5.3%−21.1%
2023-05-25Cannara Biotech IncLOVE.V$11K+0.0%−5.3%−17.9%
2023-05-24Cannara Biotech IncLOVE.V$2K+0.0%−5.3%−16.8%
2023-05-19Cannara Biotech IncLOVE.V$5K+0.0%−2.1%−14.7%
2023-05-18Cannara Biotech IncLOVE.V$5K+0.0%−3.2%−14.7%
2023-05-12Cannara Biotech IncLOVE.V$4K+0.0%−2.1%−14.7%
2023-02-13Cannara Biotech IncLOVE.V$15K+0.0%+0.0%−4.2%

Showing the latest 25 of 33 buys.

Recent insider filings

DateCompanyTypeSharesPriceBalance after
2025-12-08Cannara Biotech IncRestricted Share Units (Common Shares)Exercise of rights-25,000—45,000
2025-12-08Cannara Biotech IncCommon SharesExercise of rights25,000—401,040
2025-11-21Cannara Biotech IncOptions (Common Shares)Grant of options10,000$1.8020,000
2025-10-07Cannara Biotech IncConvertible Debentures · via Olymbec Investments IncConversion or exchange———
2025-10-07Cannara Biotech IncCommon Shares · via Olymbec Investments IncConversion or exchange3,462,763$1.8023,392,520
2025-08-28Cannara Biotech IncRestricted Share Units (Common Shares)Grant of rights20,000—70,000
2024-11-22Cannara Biotech IncRestricted Share Units (Common Shares)Grant of rights25,000—50,000
2024-08-21Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy120,500$0.76419,929,757
2024-08-15Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy63,500$0.68819,809,257
2024-07-26Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy48,000$0.62619,745,757
2024-05-21Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy6,000$0.82019,697,757
2024-05-17Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy10,000$0.82119,691,757
2024-05-16Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy10,000$0.80119,681,757
2024-05-15Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy6,000$0.79019,671,757
2024-05-14Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy6,000$0.77919,665,757
2024-05-13Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy6,000$0.79819,659,757
2024-05-10Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy21,000$0.78119,653,757
2024-05-09Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy6,000$0.73019,632,757
2024-05-08Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy6,000$0.74719,626,757
2024-05-07Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy6,000$0.76019,620,757
2024-02-29Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy50,000$1.00019,614,757
2024-02-27Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy50,000$0.95419,564,757
2023-12-06Cannara Biotech IncRestricted Share Units (Common Shares)Grant of rights25,000—25,000
2023-05-31Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy66,000$1.1319,514,757
2023-05-31Cannara Biotech IncCommon SharesBuy53,000$1.13376,040
2023-05-30Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy61,000$1.0019,448,757
2023-05-30Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy2,000$0.99019,387,757
2023-05-30Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy10,000$0.98019,385,757
2023-05-30Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy500$0.96019,375,757
2023-05-30Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy5,000$0.95019,375,257
2023-05-30Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy500$0.93019,370,257
2023-05-29Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy2,000$0.94019,369,757
2023-05-29Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy2,500$0.92019,367,757
2023-05-29Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy7,500$0.90019,365,257
2023-05-26Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy500$0.85019,357,757
2023-05-25Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy12,500$0.85019,357,257
2023-05-24Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy2,000$0.85019,344,757
2023-05-19Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy6,000$0.88019,342,757
2023-05-18Cannara Biotech IncCommon Shares · via Olymbec Investments IncBuy6,025$0.85019,336,757
2023-05-12Cannara Biotech IncCommon SharesBuy3,500$0.840323,040

Free with a Wealth Awesome account

Keep analysing Derek Elan Stern, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.

How we count it: for each company we take the latest share balance Derek Elan Stern reported on SEDI for common-type shares (held directly or through holding companies) and value it at the latest close. Options, warrants and share units are left out, and so are balances with no filing in the last three years (insiders stop reporting when they leave the role). This is not a net worth figure: it covers only Canadian-listed shares reported on SEDI, and balances can lag until the next filing.

Canada's biggest insider shareholders · Latest insider trades

Awesome Portfolio™

Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →